The Medicine Maker | The Medicine Maker

Musings from The Power List: Ann Cleves

August 11, 2026

Ann Cleves on why the future of small-molecule drug discovery lies beyond the rule of five

3 min read

Building Commercial Readiness in Advanced Therapies

Why early process development, analytical planning, and tech transfer can shape the future of cell and gene therapy manufacturing

Cell & Gene

This Week’s CGT News: In Vivo CAR T Draws Major Investment

Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes

Outsourcing

Musings from The Power List: Ali Pashazadeh

Ali Pashazadeh argues that management failures sink too many clinical programs – and explains why commercial discipline must start much earlier

Biopharma

Moving Glycosylation Control Upstream

Samsung Biologics’ Sojeong Lee discusses why biologics developers are paying closer attention to glycosylation earlier in development.

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Development & Clinical Future of Pharma Technology & Manufacturing

What Did ASCO 2026 Reveal About the Future of Oncology?

August 6, 2026

Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades

8 min read

Development & Clinical Biopharma Interviews Business & Trends

How China Is Rewriting the Rules Global Drug Development

August 5, 2026

In part two of our conversation, Lingshi Tan explores how China’s integrated biopharma ecosystem is reshaping assumptions about speed, cost, innovation, and cross-border clinical development

14 min read

Supply Chain Business & Trends Future of Pharma

Do Pharma Supply Chains Have a Visibility Problem?

August 4, 2026

A recent multimillion-dollar freezer failure highlights the urgent need for real-time visibility across the pharmaceutical supply chain

4 min read

Development & Clinical Business & Trends Biopharma

The 10 Biggest Bottlenecks Slowing Drug Development

August 4, 2026

Ten industry leaders from the 2026 Power List identify the scientific, clinical, regulatory, and financial barriers holding drug development back

6 min read

Cell & Gene Drug Discovery Research News Development & Clinical Regulation & Standards

This Week’s CGT News: Gene-Editing Trial Death Raises Concerns

August 3, 2026

A previously undisclosed death in China raises questions about gene-editing oversight, deramiocel meets its Phase 3 Duchenne endpoint, and researchers identify a source of CAR NK dysfunction

4 min read

Future of Pharma Facilities & Equipment Innovation Awards Technology & Manufacturing

2026 Innovation Awards: Nominate Now

July 31, 2026

Nominations are now open for The Medicine Maker 2026 Innovation Awards, celebrating the latest technologies for drug development and manufacturing

1 min read

Cell & Gene Development & Clinical

Musings from The Power List: Claudia Zylberberg

July 30, 2026

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

8 min read

Biopharma Facilities & Equipment Business & Trends

Why Traditional Biomanufacturing Models are Faltering

July 29, 2026

As product pipelines become more varied, biomanufacturers are rethinking how facilities, data systems and workforce skills support day-to-day operations

6 min read

Biopharma Development & Clinical Interviews Business & Trends

The New Rules of Global Drug Development

July 28, 2026

Caidya Executive Chairman Lingshi Tan explains why capital discipline, early clinical execution, and global development strategy are becoming central to biotech success

8 min read

Cell & Gene Research News

This Week’s CGT News: Off-the-Shelf CAR T Tackles Kidney Cancer

July 27, 2026

Allogeneic CAR T produces durable responses in advanced kidney cancer, the FDA clears a CD22-directed in vivo therapy, and Repligen agrees to acquire BioLife Solutions for $1.5 billion

4 min read

Top Stories